Skip to content

Insider · CIK 0001971702

Conrad Wai

ceoofficer

Files at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). First filing Jul 10, 2025, latest Sep 16, 2026.

Conrad Wai files SEC Form 4 as CEO at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE). Since Jul 10, 2025, Conrad Wai has reported 0 open-market buys worth $0 and 4 open-market sells worth $3.0M, the latest filed on Sep 16, 2026.

A track record needs three past buys with six months of prices behind them; Conrad Wai has 0, so none is measured yet.

The newest scored trade: sold $1.4M of CLOV on Sep 15, 2026, filed Sep 16, 2026, scored 50 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $2.3M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $3.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CLOV: CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOVOct 9, 2026 · close 4.79

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
CLOVsell 410b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
$1.4M
300,000 shares
-20%-
48Moderate
CLOVsell 310b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
$879k
220,426 shares
-14%+146% from low0% from high
39Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
$693k
209,797 shares
-13%+26% from low-33% from high
20Weak
CLOVsell 210b5-1
CLOVER HEALTH INVESTMENTS, CORP. /DE
$50k
15,203 shares
-1%+19% from low-37% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jul 8, 2025 CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
225,000
0.05% of outstanding
$731kJul 8, 2025none

Transactions

Every row this insider has filed, 23 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-300,000$4.72$1.4M1,170,05627 d ago
May 28, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-220,426$3.99$879k1,390,056May 28, 2026
Apr 15, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-23,463$2.04$48k1,169,914Apr 16, 2026
Apr 1, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
AGrant or award
Class A Common Stock
+267,766$0.00$01,193,377Apr 3, 2026
Mar 14, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-100,195$1.98$198k925,611Mar 17, 2026
Jan 15, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-25,868$2.81$73k1,025,806Jan 20, 2026
Dec 14, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-98,411$2.70$266k1,051,674Dec 16, 2025
Oct 31, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-96,448$3.53$340k1,178,015Nov 4, 2025
Oct 31, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-27,930$3.53$99k1,150,085Nov 4, 2025
Oct 15, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-92,181$2.80$258k1,274,463Oct 17, 2025
Sep 14, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-98,412$3.06$301k1,573,425Sep 16, 2025
Jul 31, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-27,930$2.89$81k1,671,837Aug 4, 2025
Jul 22, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-118,600$3.29$390k1,494,898Jul 24, 2025
Jul 23, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-91,197$3.32$303k1,403,701Jul 24, 2025
Sep 13, 2024CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
AGrant or award
Class A Common Stock10b5-1
+379,866$0.00$01,699,767Jul 10, 2025
Jul 8, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
SOpen-market sale
Class A Common Stockindirect: By Trust.10b5-1
-15,203$3.26$50k1,613,498Jul 10, 2025
Jun 14, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-98,411$2.89$284k3,138,535Jun 17, 2025
Apr 30, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-26,593$3.40$90k3,236,946May 2, 2025
Mar 14, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-80,524$3.66$295k3,263,539Mar 18, 2025
Jan 31, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-24,470$4.39$107k3,344,063Feb 4, 2025
Dec 14, 2024CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-98,217$3.11$305k3,368,533Dec 17, 2024
Oct 31, 2024CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
FTax withholding
Class A Common Stock
-111,496$4.12$459k3,466,750Nov 4, 2024
Oct 15, 2024CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
AGrant or award
Class A Common Stock
+726,114$0.00$03,578,246Oct 17, 2024

Questions about Conrad Wai

Answered from the filings on this page, as of the latest one.

Is Conrad Wai buying or selling?

In the last 12 months Conrad Wai reported 0 open-market buys worth $0 and 2 open-market sells worth $2.3M on SEC Form 4; the latest was sold $1.4M of CLOV on Sep 15, 2026. Grants, option exercises and tax withholding are not counted.

How did Conrad Wai's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Conrad Wai has 0.

Where does Conrad Wai file Form 4?

Conrad Wai has filed Form 4 at CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE) as CEO, Counterpart Health. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Conrad Wai: insider trades and track record | InsiderTell